Clinical Trial Update: Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating capecitabine and oxaliplatin given before, during, and after radiation therapy for advanced rectal cancer, with cetuximab added for K…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Rectum Cancer | Phase 2 | Status: UNKNOWN